Harshit Khare, Satyendra Tewari, Roopali Khanna, Aditya Kapoor. Insights on DAPT Abbreviation and De-escalation from ULTIMATE-DAPT and Related Trials: Are we Heading Toward an Aspirin-Free Strategy?. // American Journal of Cardiovascular Drugs. – 2025. – DOI: 10.1007/s40256-025-00725-0. – URL: https://doi.org/10.1007/s40256-025-00725-0
Harshit Khare, Satyendra Tewari, Roopali Khanna, & Aditya Kapoor (2025). Insights on DAPT Abbreviation and De-escalation from ULTIMATE-DAPT and Related Trials: Are we Heading Toward an Aspirin-Free Strategy?. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-025-00725-0
Harshit Khare, et al. “Insights on DAPT Abbreviation and De-escalation from ULTIMATE-DAPT and Related Trials: Are we Heading Toward an Aspirin-Free Strategy?.” American Journal of Cardiovascular Drugs, 2025. doi:10.1007/s40256-025-00725-0.
@article{Khare2025,
title = {Insights on DAPT Abbreviation and De-escalation from ULTIMATE-DAPT and Related Trials: Are we Heading Toward an Aspirin-Free Strategy?},
author = {Khare, Harshit and Tewari, Satyendra and Khanna, Roopali and Kapoor, Aditya},
journal = {American Journal of Cardiovascular Drugs},
year = {2025},
doi = {10.1007/s40256-025-00725-0},
url = {https://doi.org/10.1007/s40256-025-00725-0}
}